190 related articles for article (PubMed ID: 23241246)
1. Anti-VEGF treating macular oedema caused by retinal arteriovenous malformation - a case report.
Winter E; Elsås T; Austeng D
Acta Ophthalmol; 2014 Mar; 92(2):192-3. PubMed ID: 23241246
[No Abstract] [Full Text] [Related]
2. Periocular triamcinolone acetonide as treatment for macular edema secondary to branch vein occlusion associated with retinal arteriovenous malformation.
Federici T; Batlle I
Retina; 2006; 26(9):1079-80. PubMed ID: 17151499
[No Abstract] [Full Text] [Related]
3. Appearance of macular edema during pregnancy due to retinal arteriovenous malformation.
Capuano V; Oliverio L; Amoroso F; Srour M; Souied EH; Querques G
J Fr Ophtalmol; 2018 Oct; 41(8):e383-e385. PubMed ID: 30172380
[No Abstract] [Full Text] [Related]
4. Comment of article by Matsumoto Y.
Campa C; D'Angelo S; Incorvaia C
Retina; 2008 May; 28(5):782; author reply 782-3. PubMed ID: 18463528
[No Abstract] [Full Text] [Related]
5. Bevacizumab and macular edema.
Kumar A
Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
[No Abstract] [Full Text] [Related]
6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
7. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
Saito W; Kase S; Ohgami K; Mori S; Ohno S
Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
[TBL] [Abstract][Full Text] [Related]
10. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
11. Cat-scratch-disease-associated macular oedema treated with intravitreal ranibizumab.
Manousaridis K; Peter S; Mennel S
Acta Ophthalmol; 2015 Mar; 93(2):e168-70. PubMed ID: 24943325
[No Abstract] [Full Text] [Related]
12. 3-Dimensional Visualization of Arteriovenous Crossing in a Branch Retinal Vein Occlusion.
Lo T; Yiu G
Ophthalmology; 2021 Mar; 128(3):363. PubMed ID: 33612162
[No Abstract] [Full Text] [Related]
13. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
[TBL] [Abstract][Full Text] [Related]
14. Retinal vein occlusion: late complication of a congenital arteriovenous anomaly.
Salati C; Ferrari E; Basile R; Virgili G; Menchini U
Ophthalmologica; 2002; 216(2):151-2. PubMed ID: 11919443
[No Abstract] [Full Text] [Related]
15. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.
Campochiaro PA; Hafiz G; Channa R; Shah SM; Nguyen QD; Ying H; Do DV; Zimmer-Galler I; Solomon SD; Sung JU; Syed B
Ophthalmology; 2010 Dec; 117(12):2387-2394.e1-5. PubMed ID: 20630595
[TBL] [Abstract][Full Text] [Related]
16. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.
Matsumoto Y; Freund KB; Peiretti E; Cooney MJ; Ferrara DC; Yannuzzi LA
Retina; 2007; 27(4):426-31. PubMed ID: 17420693
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.
Sandali O; Akesbi J; Rodallec T; Laroche L; Nordmann JP
Can J Ophthalmol; 2013 Aug; 48(4):e78-80. PubMed ID: 23931489
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis.
Erdurman FC; Durukan AH; Mumcuoğlu T; Hürmeriç V
Ocul Immunol Inflamm; 2009; 17(1):56-8. PubMed ID: 19294575
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
20. Retinal artery occlusion following intravitreal anti-VEGF therapy.
von Hanno T; Kinge B; Fossen K
Acta Ophthalmol; 2010 Mar; 88(2):263-6. PubMed ID: 19416108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
